Research to evaluate safety and impact of long COVID intervention with Ensitrelvir for National Cohort (RESILIENCE Study): A protocol for a randomized, double-blind, placebo-controlled trial
This study was registered with the Japan Registry of Clinical Trials on February 16, 2024 (jRCTs051230184, https://jrct.mhlw.go.jp/en-latest-detail/jRCTs051230184).
Authors
- Shintaro Tanaka
- Ryuichi Minoda Sada (ORCID: https://orcid.org/0000-0002-1455-6822)
- Satoshi Kutsuna (ORCID: https://orcid.org/0000-0002-6929-8955)
- Shungo Yamamoto (ORCID: https://orcid.org/0000-0003-3207-8403)
- Daisuke Onozuka (ORCID: https://orcid.org/0000-0001-9596-9188)
- Kento Asano (ORCID: https://orcid.org/0009-0000-3191-3484)
- Keiji Konishi (ORCID: https://orcid.org/0000-0002-1705-6487)
- Masahiro Kinoshita (ORCID: https://orcid.org/0000-0001-6719-1241)
- Shogo Miyazawa
Institutions
- Osaka City University (JP)
- Osaka National Hospital (JP)
- Shionogi (Japan) (JP)
- Osaka International Cancer Institute (JP)
- Osaka University Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1371/journal.pone.0335609
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shionogi